AbbVie unveils diversity, climate and accessibility strategies in new report
All eyes are on AbbVie. The company’s rounding out its first decade on Wall Street this year, and over the next five, it’s predicted to beat out Pfizer to become the world’s top-selling pharma giant.
But it isn’t just about sales. More and more pharma companies are publishing reports to outline climate, societal, and even pricing goals. Last week, AbbVie laid out its strategy in its latest Environment, Social & Governance (ESG) report.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.